Professor Mark Carr
Professor Mark Carr started his research career as a PhD student in Professor Iain Campbell’s group in the Department of Biochemistry at the University of Oxford. This was followed by structural biology postdoctoral positions at the Max Planck Institute for Medical Research in Heidelberg and the National Institute for Medical Research in London, where Dr Jim Feeney encouraged him to develop his own research projects. For several years Mark worked as a group leader at the National Institute for Biological Standards and Control, before moving to the Department of Biosciences at the University of Kent as a Lecturer where he established a new centre for NMR spectroscopy-based structural biology with substantial support from the Wellcome Trust.
He was recruited to the Department of Biochemistry at Leicester in early 2001 as a Reader and continued to develop a successful research programme focussed on understanding the precise functions and molecular mechanisms of proteins and protein complexes involved in key biological processes of significant medical importance, such as tuberculosis pathogenesis and control of eukaryotic gene expression. In addition, Mark’s group has developed a very close and successful collaboration with research scientists at UCB Celltech, which promises to have a significant impact on the discovery and development of new drugs, including therapeutic antibodies.
